Cancer journal (Sudbury, Mass.)HumansArtificial IntelligenceNeoplasmsClinical Trials as TopicMedical Oncology
Harnessing Artificial Intelligence to Transform Clinical Trials and Cancer Care: Opportunities and Challenges.
Jennifer H Benbow, Edward S Kim
Published: 202510.1097/PPO.0000000000000796
Abstract
Artificial intelligence (AI) is working toward the reality of speeding up oncology drug development, offering the ability to cut years off the pipeline while maintaining patient safety and personalized care. Machine learning (ML) models analyze histo…
Preview only. Read the full abstract at the source